The U.S. National Cancer Institute (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs will provide SBIR phase II bridge awards in the 2012 fiscal year.
The awards are designed to support the next stage of development for previously funded NIH-wide SBIR phase II projects in cancer therapeutics, imaging technologies, interventional devices, diagnostics, and prognostics, according to NCI. Up to $10 million will be committed to fund up to 10 new awards.
Applications are due on December 28, 2011, and March 27, 2012. More information can be found here.
